Mind Medicine Australia FREE Webinar: Can Psilocybin Improve Human Health Span and the Biology of Ageing? with Dr Louise Hecker (USA) and Dr Macsue Jacques
With Dr Louise Hecker (USA) and Dr Macsue Jacques
Date: Wed 04 March 2026 @ 12:00pm (AEST)
Location: Webinar (online)
Join this FREE WEBINAR presented by Dr Macsue Jacques and Dr Louise Hecker (USA).
TOPIC: Can Psilocybin Improve Human Health Span and the Biology of Ageing?
This webinar will examine psilocybin research through a geroscience and systems biology lens, focusing on what psychedelic-induced distress can reveal about fundamental ageing processes across biological systems and how and why psilocybin may improve human life and health span.
Key Learning Outcomes:
- Understand ageing as a progressive loss of biological plasticity and adaptive capacity across molecular, cellular, and systemic levels.
- Review the first evidence demonstrating that psilocybin impacts ageing biology, and explore the mechanisms through which it engages conserved pathways such as inflammation, stress response, metabolic regulation, and cellular resilience.
- Examine how psilocybin influences systemic organ systems, highlighting cross-tissue and whole-body effects.
- Discuss the use of psilocybin as an experimental probe and its potential as a geroprotective agent, with relevance to flexibility, recovery, and biological reprogramming in ageing systems.
- Consider implications for healthspan science, emphasising restoration of adaptability and integrative, cross-tissue frameworks beyond single-organ models.
EVENT DETAILS
DATE: 4th March 2026
TIME: 11:55am (AEDT) for 12:00pm start, finishing at 1:15pm
DURATION: 75 minutes (incl Q&A)
LOCATION: Online – a link will be emailed to you with the viewing details
A replay of the event will be made available on our YouTube channel.
The Presenters
Dr Louise Hecker (USA)
Phd
Clinical Associate Professor: Medicine - Cardiovascular Research, Baylor College of Medicine
Louise Hecker, PhD is an Associate Professor at Baylor College of Medicine and the Founder and Chief Scientific Officer at Fibronox with over 15 years of experience in regenerative biology, fibrosis research, and age-related disease therapeutics. She is a world-leading expert on Nox4 and Nrf2, having made numerous seminal discoveries in understanding how oxidative stress contributes to tissue fibrosis and aging.
Her groundbreaking research has revolutionized the understanding of fibrotic diseases and recently expanded into psychedelic medicine, where her team discovered that psilocybin extends cellular lifespan by up to 57% and improves survival in aged mice. As an academic entrepreneur, she has founded five companies and secured approximately $15 million in research funding as Principal Investigator while holding around 20 patent applications.
Dr Macsue Jacques
Phd
Postdoctoral Researcher at Monash University
Dr Macsue Jacques is a prominent postdoctoral researcher and data scientist specializing in aging, epigenetics, and longevity science. Based at the Australian Regenerative Medicine Institute (ARMI) at Monash University, she focuses on utilizing multi-omics approaches and advanced computational tools to understand the mechanisms of aging.
Disclaimer: Mind Medicine Australia does not encourage or facilitate illegal use of psychedelics or plant medicines. MMA focus is focused on clinical and legal use only supported by the emerging science and legislative processes. Mind Medicine Australia reserves the right to record and publish webinars on various social media platforms. You agree that you will not discuss any names, locations or specific details of illegal use of psychedelics both verbally or via any written forms of communication via Mind Medicine Australia social media platforms (for example Facebook, Instagram or Zoom private and public chat forms during a webinar). Breaches of these guidelines may result in not being able to participate in the event. We thank you for support and cooperation on these matters.